Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Zhang, Dake ^a   Ma, Sufang ^a,d   Zhang, Xin ^b   Zhao, Hanqing ^c   Ding, Huiguo ^b   Zeng, Changqing ^a  

^a Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Medical College of Jining of Shandong   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; GUANOSINE; HEPATITIS B(E) ANTIGEN; THYMIDINE; HEPATITIS B CORE ANTIGEN; VIRUS DNA;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PROMOTER REGION; VIRUS CORE; VIRUS GENOME; CHEMISTRY; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY;

ADULT; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 77956609161     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-271     Document Type: Article

References (28)

1. Yuh CH, Chang YL, Ting LP. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol 1992, 66(7):4073-4084. 241210, 1602534.
2. Lee WM. Hepatitis B virus infection. N Engl J Med 1733, 337(24):-1745.
3. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000, 64(1):51-68. 10.1128/MMBR.64.1.51-68.2000, 98986, 10704474.
4. Tsai WL, Lo GH, Hsu PI, Lai KH, Lin CK, Chan HH, Chen WC, Cheng JS, Liu YC, Huang TS, et al. Role of genotype and precore/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation. Scand J Gastroenterol 2008, 43(2):196-201. 10.1080/00365520701745693, 18224565.
5. Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol 2008, 89(Pt 4):901-909. 10.1099/vir.0.83468-0, 18343830.
6. Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003, 124(2):327-334. 10.1053/gast.2003.50053, 12557138.
7. Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers. Liver Int 2007, 27(10):1356-1363. 10.1111/j.1478-3231.2007.01585.x, 2229667, 17900245.
8. Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, Fong DY, Fung J, Wong DK, Yuen JC, Mizokami M, et al. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 2008, 57(1):98-102. 10.1136/gut.2007.119859, 17483190.
9. Fang ZL, Sabin CA, Dong BQ, Ge LY, Wei SC, Chen QY, Fang KX, Yang JY, Wang XY, Harrison TJ. HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. Am J Gastroenterol 2008, 103(9):2254-2262. 10.1111/j.1572-0241.2008.01974.x, 2566798, 18844615.
10. Wang Z, Tanaka Y, Huang Y, Kurbanov F, Chen J, Zeng G, Zhou B, Mizokami M, Hou J. Clinical and virological characteristics of hepatitis B virus subgenotypes Ba, C1, and C2 in China. J Clin Microbiol 2007, 45(5):1491-1496. 10.1128/JCM.02157-06, 1865908, 17376881.
11. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis 2008, 198(11):1634-1642. 10.1086/592990, 18939932.
12. Tanaka Y, Mukaide M, Orito E, Yuen MF, Ito K, Kurbanov F, Sugauchi F, Asahina Y, Izumi N, Kato M, et al. Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 2006, 45(5):646-653. 10.1016/j.jhep.2006.06.018, 16935384.
13. Abbas Z, Muzaffar R, Siddiqui A, Naqvi SA, Rizvi SA. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi. BMC Gastroenterol 2006, 6:20. 10.1186/1471-230X-6-20, 1544342, 16863587.
14. Rezende RE, Fonseca BA, Ramalho LN, Zucoloto S, Pinho JR, Bertolini DA, Martinelli AL. The precore mutation is associated with severity of liver damage in Brazilian patients with chronic hepatitis B. J Clin Virol 2005, 32(1):53-59. 10.1016/j.jcv.2004.08.001, 15572007.
15. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989, 2(8663):588-591. 10.1016/S0140-6736(89)90713-7, 2570285.
16. Du H, Li T, Zhang HY, He ZP, Dong QM, Duan XZ, Zhuang H. Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection. Liver Int 2007, 27(2):240-246. 10.1111/j.1478-3231.2006.01400.x, 17311620.
17. Laras A, Koskinas J, Hadziyannis SJ. In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter. Virology 2002, 295(1):86-96. 10.1006/viro.2001.1352, 12033768.
18. Chen CH, Lee CM, Lu SN, Changchien CS, Wang JC, Wang JH, Hung CH, Hu TH. Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy. J Hepatol 2006, 44(1):76-82. 10.1016/j.jhep.2005.08.022, 16298013.
19. Huang YH, Wu JC, Chang TT, Sheen IJ, Huo TI, Lee PC, Su CW, Lee SD. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients. J Viral Hepat 2006, 13(5):336-342. 10.1111/j.1365-2893.2005.00688.x, 16637865.
20. Sendi H, Mehrab-Mohseni M, Zali MR, Norder H, Magnius LO. T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D. J Gen Virol 2005, 86(Pt 9):2451-2458. 10.1099/vir.0.81023-0, 16099903.
21. Tacke F, Gehrke C, Luedde T, Heim A, Manns MP, Trautwein C. Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants. J Virol 2004, 78(16):8524-8535. 10.1128/JVI.78.16.8524-8535.2004, 479060, 15280461.
22. Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J (Engl) 2007, 12(24):2159-2173.
23. Kumar S, Nei M, Dudley J, Tamura K. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 2008, 9(4):299-306. 10.1093/bib/bbn017, 2562624, 18417537.
24. Chevenet F, Brun C, Banuls AL, Jacq B, Christen R. TreeDyn: towards dynamic graphics and annotations for analyses of trees. BMC Bioinformatics 2006, 7:439. 10.1186/1471-2105-7-439, 1615880, 17032440.
25. Ramiere C, Scholtes C, Diaz O, Icard V, Perrin-Cocon L, Trabaud MA, Lotteau V, Andre P. Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha. J Virol 2008, 82(21):10832-10840. 10.1128/JVI.00883-08, 2573182, 18768987.
26. Kajiya Y, Hamasaki K, Nakata K, Miyazoe S, Takeda Y, Higashi S, Ohkubo K, Ichikawa T, Nakao K, Kato Y, et al. A long-term follow-up analysis of serial core promoter and precore sequences in Japanese patients chronically infected by hepatitis B virus. Dig Dis Sci 2001, 46(3):059-515.
27. Utsumi T, Yano Y, Truong BX, Tanaka Y, Mizokami M, Seo Y, Kasuga M, Kawabata M, Hayashi Y. Molecular epidemiological study of hepatitis B virus infection in two different ethnic populations from the Solomon Islands. J Med Virol 2007, 79(3):229-235. 10.1002/jmv.20791, 17245721.
28. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, Rostami Nejad M, Antikchi MH, Sabahi F, Zali MR. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect 2008, 14(9):858-866. 10.1111/j.1469-0691.2008.02053.x, 18844687.